Caroline Ward

797 total citations
20 papers, 404 citations indexed

About

Caroline Ward is a scholar working on Oncology, Hepatology and Epidemiology. According to data from OpenAlex, Caroline Ward has authored 20 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Hepatology and 6 papers in Epidemiology. Recurrent topics in Caroline Ward's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (4 papers). Caroline Ward is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (4 papers). Caroline Ward collaborates with scholars based in United Kingdom, Italy and Germany. Caroline Ward's co-authors include Rohini Sharma, David J. Pinato, E D Cooke, Paul Johnson, Patrik Rorsman, Makoto Shigeto, Jonathan N. Walker, Stefan Amisten, Quan Zhang and Reshma Ramracheya and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes and Journal of Hepatology.

In The Last Decade

Caroline Ward

18 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Ward United Kingdom 11 165 121 99 76 74 20 404
Liguang Wang China 10 115 0.7× 56 0.5× 85 0.9× 78 1.0× 52 0.7× 15 303
Yurie Soejima Japan 12 59 0.4× 82 0.7× 62 0.6× 125 1.6× 76 1.0× 33 355
Fujio Matsumura Japan 12 90 0.5× 167 1.4× 86 0.9× 60 0.8× 67 0.9× 28 396
Márcia Saldanha Kubrusly Brazil 11 52 0.3× 119 1.0× 118 1.2× 219 2.9× 111 1.5× 38 438
Nobuto Okamoto Japan 12 37 0.2× 97 0.8× 71 0.7× 121 1.6× 155 2.1× 23 342
Shigeaki Yokoyama Japan 11 62 0.4× 85 0.7× 70 0.7× 146 1.9× 42 0.6× 18 387
Dustin Staloch United States 7 69 0.4× 92 0.8× 75 0.8× 210 2.8× 86 1.2× 12 414
Zhitao Jin China 10 30 0.2× 84 0.7× 46 0.5× 193 2.5× 91 1.2× 13 384
Nathalie Colnot France 5 58 0.4× 91 0.8× 139 1.4× 55 0.7× 217 2.9× 8 314
Phaedra Tachtatzis United Kingdom 7 125 0.8× 64 0.5× 19 0.2× 87 1.1× 213 2.9× 13 390

Countries citing papers authored by Caroline Ward

Since Specialization
Citations

This map shows the geographic impact of Caroline Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Ward more than expected).

Fields of papers citing papers by Caroline Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Ward. The network helps show where Caroline Ward may publish in the future.

Co-authorship network of co-authors of Caroline Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Ward. A scholar is included among the top collaborators of Caroline Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Ward. Caroline Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fessas, Petros, Bernhard Scheiner, Antonio D’Alessio, et al.. (2023). PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma. Future Oncology. 19(7). 499–507. 3 indexed citations
3.
D’Alessio, Antonio, Madhava Pai, Duncan Spalding, et al.. (2023). Neoadjuvant immunotherapy with ipilimumab plus nivolumab and radiologically and pathologically quantifiable responses through modulation of the tumour microenvironment in resectable hepatocellular carcinoma.. Journal of Clinical Oncology. 41(16_suppl). 4129–4129. 11 indexed citations
4.
5.
Lu, Haonan, Jacob George, Mohammed Eslam, et al.. (2022). Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver Disease. Liver Cancer. 12(1). 19–31. 11 indexed citations
6.
D’Alessio, Antonio, Duncan Spalding, Thomas Talbot, et al.. (2022). Preliminary results from a phase Ib study of neoadjuvant ipilimumab plus nivolumab prior to liver resection for hepatocellular carcinoma: The PRIME-HCC trial.. Journal of Clinical Oncology. 40(16_suppl). 4093–4093. 18 indexed citations
7.
Fulgenzi, Claudia Angela Maria, Alessio Cortellini, Antonio D’Alessio, et al.. (2022). A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL.. Journal of Clinical Oncology. 40(16_suppl). e16195–e16195. 2 indexed citations
8.
Pinato, David J., Alessio Cortellini, Tom Cole, et al.. (2021). PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma. BMC Cancer. 21(1). 301–301. 58 indexed citations
9.
Pinato, David J., Alessio Cortellini, Madhava Pai, et al.. (2021). PRIME-HCC: Phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma.. Journal of Clinical Oncology. 39(15_suppl). e16131–e16131. 3 indexed citations
10.
Howell, Jessica, Stephen R. Atkinson, David J. Pinato, et al.. (2019). Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma. European Journal of Cancer. 116. 56–66. 56 indexed citations
11.
Evans, Joanne, Caroline Ward, Madhava Pai, & Rohini Sharma. (2019). Longitudinal monitoring of cell-free DNA to predict for transarterial chemo-embolization failure in hepatocellular carcinoma.. Journal of Clinical Oncology. 37(15_suppl). e14544–e14544. 2 indexed citations
12.
Evans, Joanne, David J. Pinato, Caroline Ward, Mark Thursz, & Rohini Sharma. (2019). THU-460-Longitudinal monitoring of cell-free DNA predicts for transarterial chemo-embolization failure in hepatocellular carcinoma. Journal of Hepatology. 70(1). e362–e362. 2 indexed citations
13.
Pinato, David J., Bertram Bengsch, Anwar A. Sayed, et al.. (2019). A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL. Annals of Oncology. 30. v288–v288. 22 indexed citations
14.
15.
Pinato, David J., Clarence Yen, Dominik Bettinger, et al.. (2017). The albumin–bilirubin grade improves hepatic reserve estimation post‐sorafenib failure: implications for drug development. Alimentary Pharmacology & Therapeutics. 45(5). 714–722. 35 indexed citations
16.
Ramracheya, Reshma, Caroline Ward, Makoto Shigeto, et al.. (2010). Membrane Potential-Dependent Inactivation of Voltage-Gated Ion Channels in α-Cells Inhibits Glucagon Secretion From Human Islets. Diabetes. 59(9). 2198–2208. 104 indexed citations
17.
Cheema, Tooba A., Caroline Ward, & Stephen K. Fisher. (2005). Subnanomolar Concentrations of Thrombin Enhance the Volume-Sensitive Efflux of Taurine from Human 1321N1 Astrocytoma Cells. Journal of Pharmacology and Experimental Therapeutics. 315(2). 755–763. 21 indexed citations
18.
Cooke, E D & Caroline Ward. (1990). Vicious Circles in Reflex Sympathetic Dystrophy-A Hypothesis: Discussion Paper. Journal of the Royal Society of Medicine. 83(2). 96–99. 20 indexed citations
19.
Cooke, E D, E N Glick, S.A. Bowcock, et al.. (1989). REFLEX SYMPATHETIC DYSTROPHY (ALGONEURODYSTROPHY): TEMPERATURE STUDIES IN THE UPPER LIMB. Lara D. Veeken. 28(5). 399–403. 27 indexed citations
20.
Ward, Caroline, et al.. (1987). Gastric complication of massive slow-K overdose. British journal of surgery. 74(6). 490–490. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liguang Wang Breakdown of academic impact, for papers by Yurie Soejima Breakdown of academic impact, for papers by Fujio Matsumura Breakdown of academic impact, for papers by Márcia Saldanha Kubrusly Breakdown of academic impact, for papers by Nobuto Okamoto Breakdown of academic impact, for papers by Shigeaki Yokoyama Breakdown of academic impact, for papers by Dustin Staloch Breakdown of academic impact, for papers by Zhitao Jin Breakdown of academic impact, for papers by Nathalie Colnot Breakdown of academic impact, for papers by Phaedra Tachtatzis
Rankless by CCL
2026